Dale Hanna is the Director, Cell and Gene Therapy Solutions, supporting the development of innovative solutions to support biopharma manufacturers, providers, and patients. He is responsible for supporting the development and continued innovation needed for a unified Cencora strategy that addresses cell and gene customer needs across the global enterprise.

Dale has been with Cencora for 8 years, most recently leading the Clinical & Adherence services product strategy team within the patient services organization, Lash Group.

Dale holds a bachelors in Biochemistry from High Point University and a Master’s of Science in Healthcare Transformation from the University of Texas.